An evidence-based update on myopia and interventions to retard its progression.
An evidence-based update on myopia and interventions to retard its progression.
复制标题
DOI：
10.1016/j.jaapos.2010.09.020
复制
发表时间：
2011-04
期刊：
影响因子：
1.6
通讯作者：
Young, Terri L.
中科院分区：
文献类型：
--
作者：
Leo, Seo-Wei;Young, Terri L.
近视是人类最常见的眼部疾病。随着近视患病率的增加和最近出生人群中发病年龄的提前，近视现在影响了美国近33%的成年人，亚洲城市中85%至90%的成年人的流行比例。与西方人群中近视患病率非常低（低于5%）的儿童不同，亚洲儿童7岁时的患病率高达29%。除了近视的直接经济和社会负担之外，相关的眼部并发症可导致显著的视力丧失。本次研讨会总结了当前有关近视流行病学，遗传学，动物模型研究，危险因素和临床治疗的文献。概述了已发表的延缓儿童近视进展的治疗策略，如药物、渐进多焦点镜片、神经适应程序。
Myopia is the most common human eye disorder. With its increasing prevalence and earlier age-of-onset in recent birth cohorts, myopia now affects almost 33% of adult individuals in the United States, and epidemic proportions of 85% to 90% adult individuals in Asian cities. Unlike children in Western populations, where the prevalence of myopia is very low (less than 5%), Asian children have prevalences as high as 29% in 7-year-olds. In addition to the direct economic and social burdens of myopia, associated ocular complications may lead to substantial vision loss. This workshop summarizes the current literature regarding myopia epidemiology, genetics, animal model studies, risk factors, and clinical treatments. Published treatment strategies to retard the progression of myopia in children, such as pharmacologic agents, progressive addition lenses, neural adaptation programs are outlined.
登录
查看更多内容
影响因子：
1.4
作者：
Fulk, GW;Cyert, LA;Parker, DE
通讯作者：
Parker, DE
影响因子：
13.7
作者：
Buch, H;Vinding, T;Nielsen, NV
通讯作者：
Nielsen, NV
影响因子：
2.9
作者：
DROBE, B;DESAINTANDRE, R
通讯作者：
DESAINTANDRE, R
影响因子：
1.4
作者：
Gwiazda, J;Thorn, F;Held, R
通讯作者：
Held, R
影响因子：
4.4
作者：
Gwiazda, J;Hyman, L;Scheiman, M
通讯作者：
Scheiman, M